Oct 31, 2021/Test & Measure

The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1

Oct 11, 2023/Article

The study of Medicare beneficiaries also revealed better rates for those with higher PA levels and walking ability.

Feb 1, 2014/Test & Measure

Counter Movement Jump (CMJ) – Achilles Tendinitis

Oct 18, 2019/News

A coalition of health and professional organizations including APTA is making it clear: exercise has a crucial role to play in both the prevention of cancer and improving quality of life for individuals who have been diagnosed.

Mar 11, 2020/Roundup

Guidance for HHAs, SNFs, hospices, and more.

Jan 4, 2023/CPG

This guideline recommends measurement tools that health care providers should use to screen for and assess cancer-related fatigue in individuals with cancer.

Jun 29, 2017/News

Few CPGs exist to help clinicians diagnose upper quadrant lymphedema secondary to cancer. The APTA Oncology Section set out to change that with the publication of a new guideline in PTJ.

Jan 10, 2013/Test & Measure

For patients with foot and ankle disorders

Jan 10, 2013/Test & Measure

Used to evaluate symptoms of Achilles tendinopathy and their effect on physical activity; can be used to determine clinical severity and provide a guideline for treatment and for monitoring the effect of treatment.

Sep 11, 2023/Test & Measure

Used to stage Parkinson disease by level of severity related to impairments, especially postural instability, and activity limitations.